Related references
Note: Only part of the references are listed.Relation of Serum Adiponectin Levels to Number of Traditional Atherosclerotic Risk Factors and All-Cause Mortality and Major Adverse Cardiovascular Events (from the Copenhagen City Heart Study)
Soren Lindberg et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Heart Disease and Stroke Statistics-2013 Update A Report From the American Heart Association
Alan S. Go et al.
CIRCULATION (2013)
Iron Metabolism Is Associated With Adipocyte Insulin Resistance and Plasma Adiponectin The Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study
Nick Wlazlo et al.
DIABETES CARE (2013)
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype Action LADA 7
Mohammed I. Hawa et al.
DIABETES CARE (2013)
Association of Glycation Gap With Mortality and Vascular Complications in Diabetes
Ananth U. Nayak et al.
DIABETES CARE (2013)
Economic Costs of Diabetes in the U.S. in 2012
DIABETES CARE (2013)
Variables Involved in the Discordance between HbA1c and Fructosamine: The Glycation Gap Revisited
Carles Zafon et al.
PLOS ONE (2013)
Multimarker approach for identifying and documenting mitigation of cardiovascular risk
Marc S. Penn et al.
FUTURE CARDIOLOGY (2013)
Heart Disease and Stroke Statistics-2012 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2012)
Trends in Death Rates Among US Adults With and Without Diabetes Between 1997 and 2006 Findings from the National Health Interview Survey
Edward W. Gregg et al.
DIABETES CARE (2012)
Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study
J. Montonen et al.
DIABETOLOGIA (2012)
SUCCESSFUL TREATMENT OF PREDIABETES IN CLINICAL PRACTICE: TARGETING INSULIN RESISTANCE AND β-CELL DYSFUNCTION
John Armato et al.
ENDOCRINE PRACTICE (2012)
Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism
C. C. M. Moors et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study
Leigh Perreault et al.
LANCET (2012)
Cardiovascular risk in double diabetes mellitus-when two worlds collide
Stephen J. Cleland
NATURE REVIEWS ENDOCRINOLOGY (2012)
C-Peptide: A New Mediator of Atherosclerosis in Diabetes
Dusica Vasic et al.
MEDIATORS OF INFLAMMATION (2012)
Measuring Adiposity in Patients: The Utility of Body Mass Index (BMI), Percent Body Fat, and Leptin
Nirav R. Shah et al.
PLOS ONE (2012)
Adipocytokines, Hepatic and Inflammatory Biomarkers and Incidence of Type 2 Diabetes. The CoLaus Study
Pedro Marques-Vidal et al.
PLOS ONE (2012)
Thrombosis and obesity: Cellular bases
Roberto Lorenzet et al.
THROMBOSIS RESEARCH (2012)
Molecular Mechanisms of Diabetes and Atherosclerosis: Role of Adiponectin
Ken Kishida et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Karin E. Bornfeldt et al.
CELL METABOLISM (2011)
Biomarkers for the Prediction of Type 2 Diabetes and Cardiovascular Disease
C. Herder et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Nontraditional Markers of Glycemia Associations with microvascular conditions
Elizabeth Selvin et al.
DIABETES CARE (2011)
Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS)
R. C. Loopstra-Masters et al.
DIABETOLOGIA (2011)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN: EXECUTIVE SUMMARY
Yehuda Handelsman et al.
ENDOCRINE PRACTICE (2011)
Biomarkers in Type 2 diabetes: improving risk stratification with the PreDx® Diabetes Risk Score
Janice A. Kolberg et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Preservation of β-Cell Function: The Key to Diabetes Prevention
Ralph A. DeFronzo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Sixteen years and counting: an update on leptin in energy balance
Laurent Gautron et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Effects of leptin and adiponectin on pancreatic β-cell function
Yong-ho Lee et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Leptin and the Central Nervous System Control of Glucose Metabolism
Gregory J. Morton et al.
PHYSIOLOGICAL REVIEWS (2011)
Impact of A1C Screening Criterion on the Diagnosis of Pre-Diabetes Among U.S. Adults
Devin M. Mann et al.
DIABETES CARE (2010)
Leptin and the Control of Body Weight: A Review of Its Diverse Central Targets, Signaling Mechanisms, and Role in the Pathogenesis of Obesity
Ashwini Oswal et al.
OBESITY (2010)
α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population
Walter E. Gall et al.
PLOS ONE (2010)
Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1
Tihamer Orban et al.
DIABETES CARE (2009)
Pathogenesis and Pathophysiology of the Cardiometabolic Syndrome
Erik P. Kirk et al.
JOURNAL OF CLINICAL HYPERTENSION (2009)
Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors
Charles A. Reasner
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Tissue-specific alterations of glucose transport and molecular mechanisms of intertissue communication in obesity and type 2 diabetes
T. E. Graham et al.
HORMONE AND METABOLIC RESEARCH (2007)
Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the First Law of Thermodynamics
Robert H. Lustig
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2006)
Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose
MA Abdul-Ghani et al.
DIABETES CARE (2006)
Association between serum ferritin and the insulin resistance syndrome in a representative population
CE Wrede et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Mechanisms of disease: pathway-selective insulin resistance and microvascular complications of diabetes
PH Groop et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2005)
NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older
CM Alexander et al.
DIABETES (2003)
Share Paper
